764
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Radiolabelled nanohydroxyapatite with 99mTc: perspectives to nanoradiopharmaceuticals construction

, , &
Pages 88-91 | Received 05 Feb 2013, Accepted 04 Mar 2013, Published online: 16 Apr 2013

References

  • Ciobanu CS, Massuyeau F, Constantin LV, Predoi D. 2011. Structural and physical properties of antibacterial Ag-doped nao-hydroxyapatite synthesized at 100°C. Nanoscale Res Lett. 6:613.
  • Farokhzad OC, Langer R. 2009. Impact of nanotechnology on drug delivery. ACS Nano. 27:16–20.
  • Ibrahim DM, Mostafa AA, Korowash SA. 2011. Chemical characterization of some substituted hydroxyapatite. Chem Cent J. 28:74.
  • Jain KK. 2005. Nanotechnology-based drug delivery for cancer. Technol Cancer Res Treat. 4:407–416.
  • Jain KK. 2007. Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev Neurother. 7:363–372.
  • Lock J, Liu H. 2011. Nanomaterials enhace osteogenic differentiation of human mesenchymal stem cells similar to a short peptide of BMP-7. Int J Nanomedicine. 6:2769–2777.
  • Morelli C, Maris P, Sisci D, Perrotta E, Brunelli E, Perrota I, et al. 2011. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells. Nanoescale. 3:3198–3207.
  • Reuvenie T, Motie M, Romman Z, Popovtzer A, Popovtzer R. 2011. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study. Int J Nanomed. 6:2859–2864.
  • Sa LTM, Pessoa C, Meira AS, Silva MI, Missailidis S, Santos-Oliveira R. 2012. Development of nanoaptamers using a mesoporous sílica model labelled with 99mTc for cancer targeting. Oncology. 82: 213–217.
  • Yan-Zhong Z, Yan-Yan H, Jun Z, Shai-Hong Z, Zhi-ou L, Ke-Chao Z. 2011. Characteristics of functionalized nano-hidroxyapatite and internalization by human epithelial cell. Nanoscale Res Lett. 23:2–8.
  • Zhun J, Wang H, Liao L, Zhao L, Zhou L, Yu M, et al. 2011. Small mesoporous silica nanoparticles as carriers for enhanced photodynamic therapy. Chem Asian J. 6:2332–2338.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.